ANAB
Anaptysbio
$50.50
+$0.87 (+1.75%)Oct 28, 2026
Key metrics
The numbers that frame ANAB today
- Market cap
- $1.51B
- P/E (TTM)
- 8.8
- EV / FCF
- 90.6
- Gross margin
- 100%
- EV / Sales
- 6.9
- ROIC
- 3.6%
- Div yield
- 0%
- Debt / equity
- 25.5
- 52wk Low
- $20.99
- 52wk High
- $72.36
Growth
Revenue and earnings trend for ANAB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ANAB
Is Anaptysbio a good buy?
Yes. Anaptysbio has strong quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Anaptysbio is selling at a fair price.
What is the market capitalization of ANAB?
Anaptysbio's market capitalization is $1.51B.
What is the P/E (TTM) ratio for ANAB stock?
Anaptysbio's P/E (TTM) ratio is 8.8, based on trailing earnings.
What is the 52-week high for ANAB stock?
The 52-week high for Anaptysbio is $72.36. The current close of $50.50 is 30.2% below that high.
What is the 52-week low for ANAB stock?
The 52-week low for Anaptysbio is $20.99. The current close of $50.50 is 140.5% above that low.
Does ANAB stock pay dividends?
Anaptysbio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ANAB?
Anaptysbio's Debt / Equity ratio is 25.47.